[1] 唐立.中国肠道微生态学研究的实践[J].胃肠病学和肝病学杂志,2019,28(3):241-244.
[2] YuW,Yuan X,Xu X,et al. Reduced airway microbiota diversity is associated with elevated allergic respiratory inflammation[J].Ann Allergy Asthma Immunol,2015,115(1):63-68.
[3] 吴美平,魏庆双,陈婷,等.肠道微生态在中医药研究中的现状与展望[J].中国中医基础医学杂志,2019,25(3):406-409.
[4] 濮文渊,汪志霞,周春祥,等.肠道微生态与中医药抗肿瘤机制的相关性探讨[J].中医杂志, 2019,60(3):210-213.
[5] MatsuokaK,Kanai T. The gut microbiota and inflammatory bowel disease[J].Semin Immunopathol,2015,37(1):47-55.
[6] Kostic AD,Xavier RJ,Gevers D.The microbiome in inflammatory bowel disease:current status and the future ahead[J]. Gastroenterology, 2014,146(6):1489-1499.
[7] Sha S,Xu B,Wang X,et al.The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease[J].Diagn Microbiol Infect Dis,2013,75(3):245-251.
[8] Dubinsky M, Braun J. Diagnostic and prognostic microbial biomarkers in inflammatory bowel diseases[J]. Gastroenterology,2015, 149(5):1265-1274.
[9] 蔚晓霞,刘占举,胡艺,等.炎症性肠病患者的肠道菌群分布与血清TNF-α与IL-6水平的相关性[J].现代生物医学进展,2017,17(16):3076-3078.
[10] 叶雅丽,闫李侠.肠道菌群分析及粪便炎性标志物检测在炎症性肠病活动度评估中的作用[J].中国微生态学杂志,2018,30(3):312-316,326.
[11] Lobatón T, Domènech E. Bacterial intestinal superinfections in inflammatory bowel diseases beyond clostridum difficile[J]. Inflamm Bowel Dis,2016, 22(7):1755-1762.
[12] 曹卉,王伟,卢锐锋,等.活动期与缓解期溃疡性结肠炎患者黏膜主要菌群研究[J].中华实验外科杂志,2016,33(4):1109-1112.
[13] 张婷,陈烨,王中秋,等.炎症性肠病患者肠道菌群结构的变化及其与炎性指标的关系[J].南方医科大学学报,2013,33(10):1474-1477.
[14] 张艳丽,刘新风,于秀娟,等.炎症性肠病患者肠道菌群变化及其与炎性因子的相关性[J].山东医药,2015,55(10):79-80.
[15] 贺欣.丁酸盐在TNBS诱导的结肠炎小鼠中的保护作用研究[D].郑州:郑州大学,2018.
[16] Thibault R,Blachier F,Darcy-Vrillon B,et al.Butyrate utilization by the colonic mucosa in inflammatory bowel diseases:a transport deficiency[J]. Inflamm Bowel Dis,2010,16(4):684-695.
[17] Atarashi K,Tanoue T,Shima T, et al.Induction of colonic regulatory T cells by indigenous Clostridium species[J].Science, 2011,331(6015):337-341.
[18] 李亚周, 江慧琴, 秦阳华. 肠道真菌菌群和炎症性肠病[J]. 世界华人消化杂志.2017, 25(17):1528-1535.
[19] Sokol H, Leducq V, Aschard H,et al. Fungal microbiota dysbiosis in IBD[J]. Gut 2017, 66(6):1039-1048.
[20] 何琴,戴伟,唐春,等.克罗恩患者肠黏膜炎性区域真菌菌群组成变化研究[J].肠外与肠内营养,2017,24(6):369-373.
[21] Jawhara S,Thuru X,Standaert-vitse A,et al.Colonization of mice by Candida albicans is promoted by chemically induced colitis and augments inflammatory responses through galectin 3[J].J Infect Dis,2008,197(7):972-980.
[22] Jawharas S,Poulain D.Saccharomyces boulardii decreases inflammation and intestinal colonization by Candia albicans in a mouse model of chemically-induced colitis[J].Med Mycol,2007,45(8):691-700.
[23] RichardML,Lamas B,Liguori G,et al.Gut fungal microbiota:The Yin and Yang of inflammatory bowel disease[J].Inflamm Bowel Dis,2015,21(3):656-665.
[24] Sendid B,Quinton JF,Charrier G, et al.Anti-Saccharomyces cerevisiae,mannan antibodise inflamilial Crohn's disease[J].Am J Gastroenterol,1998,93(8):1306-1310.
[25] Mokili JL, Rohwer F, Dutilh BE. Metagenomics and future perspectives in virus discovery[J]. Curr Opin Virol 2012,2(1):63-77.
[26] Norman JM, Handley SA,Baldridge MT, et al. Disease-specifific alterations in the enteric virome in inflflammatory bowel disease[J]. Cell 2015,160(3):447-460.
[27] Cornuault JK, Petit MA, Mariadassou M,et al. Phages infecting Faecalibacterium prausnitzii belong to novel viral genera that help to decipher intestinal viromes[J]. Microbiome,2018,6(1):65.
[28] 吉阳, 黎锐平, 王明丽. 人巨细胞病毒感染与炎症性肠病的相关研究进展[J]. 世界华人消化杂志,2012, 20(22):2070-2074.
[29] 刘晨晨,张振玉.巨细胞病毒感染与炎症性肠病的关系[J].世界华人消化杂志,2015,23(11):1784-1790.
[30] 程远, 王静, 程计林.乙型、丙型肝炎与炎症性肠病[J].胃肠病学和肝病学杂志,2009,18(10):883-885.
[31] Rajili?-Stojanovi? M, Biagi E, Heilig HG,et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome[J]. Gastroenterology, 2011, 141(5):1792-1801.
[32] Bailey MT,Dowd SE,Galley JD,et al. Exposure to a social stressor alters the structure of the intestinal microbiota:Implications for stressor-induced immunomodulation[J].Brain Behav Immun,2011,25(3):397-407.
[33] Xu D,Gao J,Gillilland M,et al.Rifaximin alters intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in rats[J].Gastroenterology,2014,146(2):484-496.
[34] Reis DJ, Ilardi SS, Punt SEW.The anxiolytic effect of probiotics:a systematic review and meta-analysis of the clinical and preclinical literature[J].PLoS One,2018,13(6):e0199041.
[35] Pinto-SanchezMI,Hall GB,Ghajar K,et al. Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity:apilot study in patients with irritable bowel syndrome[J].Gastroenterology,2017,153(2):448-459.
[36] Wensaas KA,Langeland N,Hanevik K,et al.Irritable bowel syndrome and chronic fatigue 3 years after acute giardiasis:historic cohort study[J]. Gut,2012,61(2):214-219.
[37] Wang LH,Fang XC,Pan GZ. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis[J].Gut,2004,53(8):1096-1101.
[38] Ferlay J,Soerjomataram I,Dikshit R,et al.Cancer incidence and mortality worldwide:sources, methods and major patterns in GLOBOCAN2012[J].Int J Cancer, 2015, 136(5):E359-E386.
[39] Tsoi H,Chu ESH,Zhang X,et al.Peptostreptococcus anaerobius induces intracellular cholesterol biosynthesis in colon cells to induce proliferation and causes dysplasia in mice[J].Gastroenterology, 2017,152(6):1419-1433.
[40] Zackular JP,Rogers MA,Ruffin MT,et al.The human gut microbiome as a screening tool for colorectal cancer[J].Cancer Prev Res (Phila),2014,7(11):1112-1121.
[41] Flemer B,Lynch DB,Brown JM,et al.Tumour-associated and nontumour-associated microbiota in colorectal cancer[J].Gut, 2017,66(4):633-643.
[42] KatoI,Boleij A,Kortman GA,et al.Partia lassociations of dietary iron, smoking and intestinal bacteria with colorectal cancer risk[J]. Nutr Cancer, 2013, 65(2):169-177.
[43] 刘思德,陈烨,秘文婷.肠道微生态与大肠癌[J].现代消化及介入诊疗,2019,24(1):1-2.
[44] Boleij A,Hechenbleikner EM,Goodwin AC,et al.The bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients[J].Clin Infect Dis,2015,60(2),208-215.
[45] 《现代消化及介入诊疗》杂志共识专家组.肠道微生态与大肠癌相关性研究专家共识[J].现代消化及介入诊疗,2019,24(1):105-108.
[46] Yu T,Guo F,Yu Y,et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy[J].Cell,2017,170(3):548-563.
[47] Azucena R,Michael TH.Drugs,bugs,and cancer:Fusobacterium nucleatum promotes chemoresistance in colorectal cancer[J].Cell,2017,170(3):411-413.
[48] Kostic AD,Chun E,Robertson L,et al.Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment[J].Cell Host Microbe,2013,14(2):207-215.
[49] Arthur JC,Perez-Chanona E,Muhlbauer M,et al. Intestinal inflammation targets cancer-inducing activity of the microbiota[J]. Science,2012,338(6103):120-123.
[50] Elinav E,Nowarski R,Thaiss CA, et al. Inflammation-induced cancer:Crosstalk between tumours, immune cells and micro organisms[J]. Nat Rev Cancer, 2013, 13(11):759-771.
[51] Worthley DL,Whitehall VL,LeLeu RK, et al.DNA methylation in the rectal mucosa is associated with crypt proliferation and fecal short-chain fatty acids[J]. Dig Dis Sci, 2011, 56(2):387-396.